Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa
source: unsplash.com

Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa

According to a story from VICE News, Congressman George Santos was recently elected to Congress in the 2022 mid-term elections. Since then, his past has been placed under scrutiny, and…

Continue Reading Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa

Raising Awareness of Recessive Dystrophic Epidermolysis Bullosa: Patterson’s Story (Pt. 2)

Before you read on, make sure to check out Part 1 of our interview, where Annie, Peter, and Patterson discuss what recessive dystrophic epidermolysis bullosa (RDEB) is, Patterson's diagnostic journey, and how…

Continue Reading Raising Awareness of Recessive Dystrophic Epidermolysis Bullosa: Patterson’s Story (Pt. 2)
Study Shares Calcipotriol Benefits for Dystrophic Epidermolysis Bullosa
jniittymaa0 / Pixabay

Study Shares Calcipotriol Benefits for Dystrophic Epidermolysis Bullosa

People with epidermolysis bullosa (EB) often experience symptoms such as intense itching or severe pain. Unfortunately, these symptoms can be debilitating and may greatly affect overall quality-of-life. However, some burgeoning…

Continue Reading Study Shares Calcipotriol Benefits for Dystrophic Epidermolysis Bullosa

Two Epidermolysis Bullosa Nonprofits United to Make the Largest Global Organization for EB

EB Research Partnership (EBRP) is based out of New York, United States. EB Research Foundation (EBRF) is an organization based out of Australia with the same goals. The two organizations  have…

Continue Reading Two Epidermolysis Bullosa Nonprofits United to Make the Largest Global Organization for EB
Trial Application for Experimental Cannabinoid Epidermolysis Bullosa Treatment Gains Approval
source: pixabay.com

Trial Application for Experimental Cannabinoid Epidermolysis Bullosa Treatment Gains Approval

According to a story from prnewswire.com, the biopharmaceutical company InMed Pharmaceuticals, Inc. has recently announced that that company's Clinical Trial Application has been approved in the Netherlands. This approval will…

Continue Reading Trial Application for Experimental Cannabinoid Epidermolysis Bullosa Treatment Gains Approval
With Clinical Hold Lifted, Abeona Moves Forward with Recessive Dystrophic Epidermolysis Bullosa Trial
source: pixabay.com

With Clinical Hold Lifted, Abeona Moves Forward with Recessive Dystrophic Epidermolysis Bullosa Trial

According to a story from Benzinga, the drug company Abeona Therapeutics, Inc. has recently announced plans to move forward with its phase 3 clinical trial following the lifting of the…

Continue Reading With Clinical Hold Lifted, Abeona Moves Forward with Recessive Dystrophic Epidermolysis Bullosa Trial
Abeona Faces Clinical Hold from the FDA Ahead of Epidermolysis Bullosa Trial
Free-Photos / Pixabay

Abeona Faces Clinical Hold from the FDA Ahead of Epidermolysis Bullosa Trial

According to a story from globenewswire.com, the gene and cell therapy company Abeona Therapeutics Inc. recently announced that has received a letter from the US Food and Drug Administration (FDA)…

Continue Reading Abeona Faces Clinical Hold from the FDA Ahead of Epidermolysis Bullosa Trial

Results From First Patient Treated in Epidermolysis Bullosa Phase 2 Trial are Extremely Promising

Epidermolysis Bullosa Epidermolysis bullosa (EB) is a rare condition affecting approximately 500,000 individuals globally. Patients in the United States and Europe account for 50,000 of these individuals. The hereditary condition is…

Continue Reading Results From First Patient Treated in Epidermolysis Bullosa Phase 2 Trial are Extremely Promising